Fulminant Type 1 Diabetes Mellitus Accompanied by Positive Conversion of Anti-insulin Antibody after the Administration of Anti-CTLA-4 Antibody Following the Discontinuation of Anti-PD-1 Antibody

Internal Medicine
Michiru ShibaTakashi Akamizu

Abstract

An 80-year-old woman with malignant melanoma received 20 cycles of anti-programmed death 1 (PD-1) antibody (nivolumab) treatment and showed normal glucose tolerance. Three weeks after switching to anti-cytotoxic T-lymphocyte associated antigen 4 (CTLA-4) antibody (ipilimumab), her plasma glucose level was elevated to 639 mg/dL, her HbA1c was 7.7%, and her fastening serum C-peptide immunoreactivity was undetectable. Anti-glutamic acid decarboxylase and insulinoma-associated protein-2 antibodies were negative. She was diagnosed with fulminant type 1 diabetes mellitus (F1DM). Remarkably, her anti-insulin antibody was positively converted, and her Sialylated Carbohydrate Antigen, Krebs von den Lungen-6 levels increased after ipilimumab therapy. She possessed F1DM-susceptible Human Leukocyte Antigen-DR4. A fluorescence activated cell sorting analysis showed an altered T-cell population. This case of F1DM highlights specific mechanisms underlying pancreatic beta cell immunity.

References

Jan 5, 2000·Proceedings of the National Academy of Sciences of the United States of America·H M ZarourW J Storkus
Jan 11, 2003·Science·Shohei HoriShimon Sakaguchi
Jul 9, 2003·The Journal of Experimental Medicine·Mohammed Javeed I AnsariMohamed H Sayegh
Nov 2, 2005·The Journal of Experimental Medicine·Stuart I ManneringAnthony W Purcell
Jul 4, 2007·International Immunology·Taku Okazaki, Tasuku Honjo
Jun 3, 2010·Annals of Clinical Biochemistry·Masafumi KogaUNKNOWN Japan Diabetes Society's Committee on Research on Type 1 Diabetes
Jun 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julie R BrahmerSuzanne L Topalian
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Jul 22, 2011·Diabetes Care·Kan NakamuraUNKNOWN Research Committee on Type 1 Diabetes of the Japan Diabetes Society
Sep 14, 2011·Current Diabetes Reports·Janelle A Noble, Ana M Valdes
Nov 10, 2011·Diabetes/metabolism Research and Reviews·Akihisa Imagawa, Toshiaki Hanafusa
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Mar 9, 2013·The Journal of Clinical Endocrinology and Metabolism·Salvatore Maria CorselloFrancesco Torino
Apr 18, 2013·Thyroid : Official Journal of the American Thyroid Association·Roberto VitaSalvatore Benvenga
May 13, 2014·Diabetes/metabolism Research and Reviews·Carolina PizarroFrancisco Pérez-Bravo
Jul 20, 2014·International Immunology·Christian U Blank, Alexander Enk
Aug 28, 2015·Diabetes Care·Caroline GaudySophie Béliard
May 3, 2016·Current Opinion in Oncology·Francesco TorinoRoberto Salvatori
Jun 16, 2016·Lancet·Flemming Pociot, Åke Lernmark
Nov 20, 2016·Endocrinology, Diabetes & Metabolism Case Reports·Harris TrainerPaul Lorigan
Jan 4, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G H TelóA P Fay
Apr 2, 2017·The American Journal of Emergency Medicine·Myint Aung WinSai-Ching Jim Yeung
Jan 1, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G H TelóA P Fay

❮ Previous
Next ❯

Citations

Jul 3, 2020·Journal of Clinical Medicine·Naoko OkuraKoichi Takayama
Mar 25, 2019·Future Science OA·Nina J KarlinCurtiss B Cook
Jan 3, 2020·The Journal of Clinical Investigation·Michael Dougan, Massimo Pietropaolo
Jul 18, 2020·Clinical Medicine : Journal of the Royal College of Physicians of London·Angelos KyriacouPunith Kempegowda
Aug 26, 2020·Chinese Medical Journal·Rui ZhangLi-Nong Ji
Nov 12, 2020·Pharmaceuticals·Nicola J NasserAbed Agbarya
Jul 3, 2018·American Journal of Therapeutics·Muhammad Khalid, Saba W Aziz
Oct 23, 2020·Diabetology International·Akihisa Imagawa, Megumi Tachibana

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray
fluorescence activated cell sorting

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Adenoma, Islet Cell

Islet Cell Adenoma arises in the islet cells, which are insulin producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Adenoma here.